Skip to main content
. 2021 Oct 29;398(10316):2093–2100. doi: 10.1016/S0140-6736(21)02249-2

Figure 1.

Figure 1

Cumulative incidence curves comparing COVID-19-related admission to hospital (A), severe disease (B), and death (C) in individuals who received two versus three doses of the BNT162b2 mRNA COVID-19 vaccine

The dashed vertical line indicates day 7, on which the main analysis period begins.